- French clinical research panorama is shifting from a global to a regional perspective. The share of Eastern Europe countries inside the European Clinical research seems to be growing strongly. France, as other EU5 countries, seems to be considered by pharmaceutical companies as a highly specialised country, particularly in oncology. France should now leverage its competitive advantages in particular by facilitating administrative processes and in developing a strong ambulatory clinical research network.